Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Advinus Therapeutics Pvt. Ltd.

www.advinus.com

Latest From Advinus Therapeutics Pvt. Ltd.

Deal Watch: Takeda Continues Transaction Spree With Four More Deals

Takeda's recent deals include a license in Asian for Tesaro's PARP inhibitor Zejula. Meanwhile, Japanese rival Mitsubishi Tanabe is paying roughly $1bn to acquire Israel's NeuroDerm.

Commercial Deals

Takeda’s Planned Emerging Markets Deal: India Yay Or Nay?

Takeda tantalizingly disclosed during its third quarter results that it has set aside funds for an acquisition worth around $450m in an undisclosed emerging market. What are the likely targets?

Emerging Markets Deals

INTERVIEW: Ex-Advinus CEO’s Bittersweet Journey

Life appears to have come full circle for Advinus Therapeutics' co-founder and former CEO and managing director, Dr. Rashmi Barbhaiya, who recently moved back to the US from India. It has been a bitter-sweet journey with peaks and troughs, although the man himself would rather see any lows as "lessons learned" that come with the territory.

BioPharmaceutical Asia Pacific

New Takeda India Leadership Amid Realignment

Whether or not it's a rejig in the normal course of business isn't very clear, but Japanese pharma giant Takeda has "realigned" certain teams as it pursues plans to provide sustainable access to its medicines under a new leadership in India.

BioPharmaceutical India
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
  • Contract Research, Toxicology Testing-CRO
  • Pharmaceuticals
  • Services
  • Therapeutic Areas
  • Infectious & Viral Diseases
  • Inflammation
  • Metabolic Disorders
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Asia
      • India
  • Parent & Subsidiaries
  • Advinus Therapeutics Pvt. Ltd.
  • Senior Management
  • Rashmi Barbhaiya, PhD, CEO
    Kasim Mookhtiar, PhD, EVP, CSO
  • Contact Info
  • Advinus Therapeutics Pvt. Ltd.
    Phone: (91) 80 2839 4959
    21 & 22 Phase II Peenya Industrial Area
    Bangalore, 560 058
    India
Advertisement
Advertisement
UsernamePublicRestriction

Register